Orthofix Medical, Inc. (OFIX) CEO Jon Serbousek on Q2 2020 Results - Earnings Call Transcript

SA Transcripts
153.96K Followers

Q2: 2020-08-06 Earnings Summary

EPS of -$0.96 beats by $0.05
 | Revenue of $73.14M (-36.87% Y/Y) beats by $22.40M

Orthofix Medical, Inc. (NASDAQ:OFIX) Q2 2020 Results Conference Call August 6, 2020 8:30 AM ET

Company Participants

Alexa Huerta - Senior Director, IR and Finance
Jon Serbousek - President and CEO
Doug Rice - CFO

Conference Call Participants

Jeffrey Cohen - Ladenburg Thalmann
Jim Sidoti - Sidoti

Operator

Good morning, ladies and gentlemen, and welcome to the Orthofix Second Quarter 2020 Earnings Results Conference Call. [Operator Instructions] Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions]

I would now like to turn the conference over to your host Alexa Huerta, Senior Director of Investor Relations and Finance. Please go ahead.

Alexa Huerta

Thank you, operator and good morning, everyone. Welcome to the Orthofix second quarter 2020 earnings call. Joining me on the call today are, our President and Chief Executive Officer, Jon Serbousek; and Chief Financial Officer, Doug Rice. I’ll start with our safe harbor statements and then pass it over to Jon. During this call, we’ll be making forward-looking statements that involve risks and uncertainties. All statements other than those of historical facts are forward-looking statements, including any earnings guidance that we provide and any statements about our plans, beliefs, strategies, expectations, goals or objectives.

Investors are cautioned not to place undue reliance on such forward-looking statements as there is no assurance that the matters contained in such statements will occur. The forward-looking statements we will make on today’s call are based on our beliefs and expectations as of today, August 6, 2020. We do not undertake any obligation to revise or update such forward-looking statements.

Some factors that could cause actual results to be materially different from the forward-looking statements made by us on the call include the risks disclosed under the heading Risk Factors in our Form 10-K for the

Recommended For You

About OFIX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on OFIX